Our drug administration technology enables routine administration to deliver drugs to specific back-of-eye tissues, including the suprachoroidal, sub-retinal, and other small spaces.
Our drug formulations are designed to suit the unique ocular environments into which they are delivered, resulting in better drug movement and therapeutic benefits. They provide effects lasting up to 12 months from a single administration.
If you would like to discuss a potential partnership with Oxular, working with either our device or drug formulation technologies, please contact us on the form below.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.